CV DEATH HAS A NEW OPPONENT
In patients with type 2 diabetes
with high CV risk

CV DEATH 
HAS A 
NEW OPPONENT

Jardiance® (Empagliflozin) is the only type 2 diabetes pill proven to go beyond lowering A1C to reduce the risk of CV death for adults who have type 2 diabetes and heart disease
 
 

ADA 2022 guidelines for T2D management of HF & CKD patients

Document ID: PC-AE-101740

24/04/2023

Author: Boehringer Ingelheim


ADA 2022 guidelines for T2D management of HF & CKD patients
Current Time 0:00
Duration 0:45
Loaded: 22.12%
Stream Type LIVE
Remaining Time 0:45
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected

    123,000
    Views

    100k 340

    Related content

     
    PC-AE-101740
    Production date: April 2023